Skip to main content
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Default Author Avatar IUSM Logo

IU School of Medicine

IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability.

Showing results for IU School of Medicine

Acute myeloid leukemia discovery tackles drug-resistant gene mutations

Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer.

IU School of Medicine  |  Jun 20, 2024

Increased expression of gene improves Alzheimer's disease symptoms

A new study by IU School of Medicine researchers has found that increased expression of a gene linked to Alzheimer's disease helped improve characteristics of the disease in mouse models. Gene expression is a series of molecular events that turns on particular parts of the DNA to inform how cells function. 

IU School of Medicine  |  Jun 18, 2024

$2.6 million in grant funding to support research on genetic causes of blindness

Indiana University School of Medicine’s Yoshikazu Imanishi, PhD, was recently awarded a four-year, $2.1 million grant from the National Eye Institute and a three-year, $500,000 grant from the Foundation Fighting Blindness to study genetic causes of blindness.

IU School of Medicine  |  Jun 17, 2024

Intracerebral hemorrhage stroke outcomes improve with early minimally invasive surgery evaluated in clinical trial

Patients with an intracerebral hemorrhage have better medical outcomes when surgeons perform an early minimally invasive removal of a hematoma compared to those receiving the standard of care, according to a study published in the New England Journal of Medicine.

IU School of Medicine  |  Jun 04, 2024

Eye-tracking techniques could help primary care providers diagnose autism sooner, more accurately

Nearly 3% of all children in the United States are diagnosed with autism, according to the Centers for Disease Control and Prevention. But a collaborative team of researchers at Indiana University and Purdue University are finding ways to make the right diagnosis sooner.

IU School of Medicine  |  May 31, 2024

Indianapolis welcomes international breath research experts for 2024 Breath Summit

More than 100 breath research specialists from around the world are expected in Indianapolis this summer for the 2024 Breath Summit.

IU School of Medicine  |  May 30, 2024

IU School of Medicine researchers to present respiratory therapy advancements at ATS 2024

IU School of Medicine researchers led by Benjamin Gaston, MD, will showcase promising respiratory disease research at the American Thoracic Society (ATS) 2024 International Conference and ATS 2024 Respiratory Innovation Summit (RIS), May 17-22 in San Diego, California.

IU School of Medicine  |  May 17, 2024

IU School of Medicine graduates new health care professionals

Indiana University School of Medicine honored the Class of 2024 graduates with a commencement ceremony Friday at the Indiana Convention Center.

IU School of Medicine  |  May 10, 2024

Biomarker found to help identify cells that can repair damaged blood vessels

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.

IU School of Medicine  |  May 07, 2024

$2.7 million grant to explore hypoxia’s impact on blood stem cells

Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature blood cells, exhibit better responses in a low-oxygen environment within the bone marrow, also known as hypoxia.

IU School of Medicine  |  Apr 25, 2024